Newsroom
23 press releases and 54 media coverage stories
For the Record – Medical Alley Interview with Josh Ludwig
Medical Alley
Catch up with the editors from Medical Alley as they interview ScaleReady Global Commercial Director, Josh Ludwig for their regular leadership platform, "For the Record".
Read the article : For the Record – Medical Alley Interview with Josh LudwigShare: For the Record – Medical Alley Interview with Josh Ludwig
Bio-Techne Announces Future Wilson Wolf Purchase Agreement
Bio-Techne
Bio-Techne announced it has entered into a purchase option agreement with Wilson Wolf Corporation, solidifying resources and support for ScaleReady to supply the entire field of cell and gene therapy…
Read the article : Bio-Techne Announces Future Wilson Wolf Purchase AgreementShare: Bio-Techne Announces Future Wilson Wolf Purchase Agreement
Bio-Techne Releases First GMP-grade Cytokines from New GMP Facility
Bio-Techne
ScaleReady sources Bio-Techne cytokines because of their commitment to supplying the entire cell and gene therapy industry with GMP-grade, animal free proteins. Bio-Techne recently launched its new, dedicated GMP facility.
Read the article : Bio-Techne Releases First GMP-grade Cytokines from New GMP FacilityShare: Bio-Techne Releases First GMP-grade Cytokines from New GMP Facility
CancerNetworks Interviews ScaleReady
cancernetwork.com
Josh Ludgwig, Global Director of Commercial Operations at ScaleReady discusses what makes the company uniquely positioned to support manufacturing across the entire cell and gene therapy industry. This interview is…
Read the article : CancerNetworks Interviews ScaleReadyShare: CancerNetworks Interviews ScaleReady
ScaleReady Joins the Alliance for Regenerative Medicine
alliancerm.org
As a member of The Alliance for Regenerative Medicine (ARM), ScaleReady committed to progressing regenerative medicine and advanced therapy manufacturing using its innovative and high throughput manufacturing platform.
Read the article : ScaleReady Joins the Alliance for Regenerative MedicineShare: ScaleReady Joins the Alliance for Regenerative Medicine
RegMedNet interviews Josh Ludwig, Global Commercial Director
RegMedNet
In this interview, Josh Ludwig, Global Director of Commercial Operations at ScaleReady, describes how a scalable, cost-effective and practical manufacturing platform for cell and gene therapies (CGTs) can be achieved.
Read the article : RegMedNet interviews Josh Ludwig, Global Commercial DirectorShare: RegMedNet interviews Josh Ludwig, Global Commercial Director
